Food and Drug Administration (FDA) approved a groundbreaking oral GLP-1 weight-loss medication the Wegovy pill from Novo Nordisk marking the first time a glucagon-like peptide-1 (GLP-1) receptor agonist for weight management can be taken as a daily tablet rather than by injection
Weve got youheres a head-to-head comparison of retatrutide vs tirzepatide vs semaglutide
Women tell me they havent changed their eating habits or exercise routine, but suddenly they have this weight gain that they cant explain, says menopause specialist Gisele Thissen, MSN, FNPC, NCMP, a clinician at Midi Health
So you draw up 20 units on your U-100 syringe to deliver a 0.5mg dose from a 2.5mg/mL vial
There are no brand name medicines that lower total medical cost over a population, and generally health economists believe that drugs that cost less than $100,000 or $150,000 per QALY are high value. Implications for employers: The net cost of GLP-1 drugs is already just 42% of the list price, so a 50% list price cut might not lead to employer savings
